| electroCore, Inc. (ECOR) Q1 2025 Earnings Call Transcript |
electroCore, Inc. (NASDAQ:ECOR ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Dan Goldberger - Chief Executive Officer and Director Joshua Lev - Chief Financial Officer Conference Call Participants Tyler Bussian - Brookline Capital Operator Greetings, and welcome to the electroCore First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed in a listen-only mode. |
seekingalpha.com |
2025-05-08 03:16:56 |
Czytaj oryginał (ang.) |
| ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates |
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.53 per share a year ago. |
zacks.com |
2025-05-07 23:20:51 |
Czytaj oryginał (ang.) |
| electroCore Announces First Quarter 2025 Financial Results |
First quarter 2025 net sales of $6.7 million, an increase of 23% over first quarter 2024 Closed the acquisition of NeuroMetrix, Inc. (“NeuroMetrix”); first quarter 2025 unaudited Quell net sales of approximately $170,000 Company to host a conference call and webcast today, May 7, 2025 at 4:30 PM EDT ROCKAWAY, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic technology company, today announced financial results for the first quarter ended March 31, 2025. |
globenewswire.com |
2025-05-07 20:05:00 |
Czytaj oryginał (ang.) |
| electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies |
Addition of Quell® Platform Broadens electroCore's Bioelectronic Technology Portfolio and Accelerates Growth in Chronic Pain and Wellness Markets Addition of Quell® Platform Broadens electroCore's Bioelectronic Technology Portfolio and Accelerates Growth in Chronic Pain and Wellness Markets |
globenewswire.com |
2025-05-02 12:00:00 |
Czytaj oryginał (ang.) |
| electroCore's Truvaga™ Now Works with the Apple Health app |
ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health app. |
globenewswire.com |
2025-05-01 12:00:00 |
Czytaj oryginał (ang.) |
| electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 |
ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended March 31, 2025, after the close of the market on Wednesday, May 7, 2025. |
globenewswire.com |
2025-04-30 12:00:00 |
Czytaj oryginał (ang.) |
| Ecora Resources expects stronger Q2 after solid start to 2025 |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has posted what it described as a “solid start” to the year, reporting a $6 million portfolio contribution in the first quarter of 2025, down from $6.7 million in the previous quarter due to the timing of cobalt deliveries from Voisey's Bay. Chief executive Marc Bishop Lafleche said volume growth is expected to accelerate in the second quarter, with a number of key assets coming back into play. |
proactiveinvestors.co.uk |
2025-04-23 07:08:53 |
Czytaj oryginał (ang.) |
| gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries |
ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that new data presented at the 2025 International Brain Injury Association World Congress highlights the effectiveness of gammaCore® non-invasive vagus nerve stimulation (nVNS) in treating concussive symptoms associated with mild traumatic brain injury (mTBI). |
globenewswire.com |
2025-04-17 12:00:00 |
Czytaj oryginał (ang.) |
| electroCore to Participate at the Planet MicroCap Showcase |
ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet MicroCap Showcase taking place at the Paris Hotel & Casino in Las Vegas on April 23 & 24, 2025. |
globenewswire.com |
2025-04-16 12:00:00 |
Czytaj oryginał (ang.) |
| electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times |
ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one of “The Americas' Fastest Growing Companies 2025. |
globenewswire.com |
2025-04-03 12:00:00 |
Czytaj oryginał (ang.) |
| electroCore to Participate at the Needham Virtual Healthcare Conference |
ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 10, 2025. |
globenewswire.com |
2025-04-01 12:00:00 |
Czytaj oryginał (ang.) |
| electroCore Extends VA Contract for Five Years |
ROCKAWAY, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that electroCore has received a new Federal Supply Schedule (FSS) contract, with an effective date of June 15, 2025 and running through June 14, 2030. |
globenewswire.com |
2025-03-31 12:00:00 |
Czytaj oryginał (ang.) |
| Ecora eyes strong 2025 as copper and cobalt streams ramp up |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) is expecting a sharp increase in royalty income in 2025, driven by rising production volumes across its copper and cobalt assets and supported by what it called positive commodity price "tailwinds". The London- and Toronto-listed royalty and streaming company, which focuses on critical minerals, said on Thursday that it anticipates meaningful growth in volumes this year, underpinned by operational momentum at key producing sites and contributions from its recently acquired copper stream over the Mimbula mine. |
proactiveinvestors.co.uk |
2025-03-27 06:08:00 |
Czytaj oryginał (ang.) |
| electroCore, Inc. (ECOR) Q4 2024 Earnings Call Transcript |
electroCore, Inc. (NASDAQ:ECOR ) Q4 2024 Results Conference Call March 12, 2025 5:30 PM ET Company Participants Dan Goldberger - CEO & Director Joshua Lev - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Tyler Bussian - Brookline Capital Operator [Call Starts Abruptly] As part of our ongoing efforts to reduce costs and drive profitability, management has opted to host this earnings call on Zoom rather than using a more costly service provider. This will be our first time hosting the call independently, so we appreciate your patience as we work through any potential technical issues. |
seekingalpha.com |
2025-03-12 23:36:06 |
Czytaj oryginał (ang.) |
| electroCore Announces Full Year 2024 Financial Results |
Record f ull year 2024 net sales of $ 25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCore TM in the United States Department of Veteran Affairs and United States Department of Defense (VA) and 174% increase in Truvaga TM sales |
globenewswire.com |
2025-03-12 18:05:00 |
Czytaj oryginał (ang.) |
| electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2024 Financial Results on Wednesday, March 12, 2025 |
ROCKAWAY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2024, after market close on Wednesday, March 12, 2025. |
globenewswire.com |
2025-03-06 10:00:00 |
Czytaj oryginał (ang.) |
| electroCore to Participate at Upcoming Investor Conferences |
Management to Attend the 37th Annual Roth Conference and the LSI USA '25 Management to Attend the 37th Annual Roth Conference and the LSI USA '25 |
globenewswire.com |
2025-03-05 10:00:00 |
Czytaj oryginał (ang.) |
| Ecora Resources landed a significant copper deal - ICYMI |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) this week unveiled a significant new deal that promises to elevate its commodity diversification efforts to a new level. It is acquiring an interest in a copper revenue stream in the Moxico Resources' Mimbula copper mine in Zambia, which is set to undergo an expansion and ramp up in production CEO Marc Bishop Lafleche joined the Proactive studio, and told us that the $50 million transaction aligns with Ecora's strategy of focusing on royalties and streams over producing mines, contributing to immediate earnings and cash flow growth. |
proactiveinvestors.co.uk |
2025-03-01 07:03:55 |
Czytaj oryginał (ang.) |
| electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal |
ROCKAWAY, N.J., Feb. 27, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Sparrow Ascent™ by Spark Biomedical, an FDA cleared non-invasive transcutaneous auricular neuromodulation device available by prescription for the treatment of opioid withdrawal symptoms, will be distributed by electroCore, Inc. within certain Department of Veterans Affairs (VA) facilities. |
globenewswire.com |
2025-02-27 10:00:00 |
Czytaj oryginał (ang.) |
| Ecora Resources acquires copper stream in $50mln deal |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has acquired a copper stream from Moxico Resources' Mimbula copper mine in Zambia for $50 million. The stream covers the mine's 11-year Life of Mine (LOM) with potential for extension. |
proactiveinvestors.co.uk |
2025-02-27 04:38:50 |
Czytaj oryginał (ang.) |
| electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's Why |
electroCore (ECOR) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. |
zacks.com |
2025-02-12 11:51:19 |
Czytaj oryginał (ang.) |
| electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held February 11-12, 2025 in Snowbird, Utah. |
globenewswire.com |
2025-02-04 10:00:00 |
Czytaj oryginał (ang.) |
| Ecora Resources getting no credit for significant growth potential, says broker |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) reported portfolio income of US$63 million for 2024 was slightly higher than market estimates, says broker Peel Hunt. Management highlighted that the contingent consideration of US$5m from Narrabri has started to be received, with US$3m reaching Ecora's bank accounts in January, significantly sooner than we had expected. |
proactiveinvestors.co.uk |
2025-01-29 12:08:05 |
Czytaj oryginał (ang.) |
| Ecora Resources boosted by record copper and cobalt production |
Royalty specialist Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) said its income in its fourth quarter was boosted by record production volumes at the Voisey's Bay (cobalt) and Mantos Blancos (copper). As a result, income from its portfolio rose 29% to US$6.7 million in the quarter from the same period a year ago. |
proactiveinvestors.co.uk |
2025-01-29 04:36:15 |
Czytaj oryginał (ang.) |
| Here's Why Momentum in electroCore (ECOR) Should Keep going |
If you are looking for stocks that are well positioned to maintain their recent uptrend, electroCore (ECOR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. |
zacks.com |
2025-01-27 11:51:11 |
Czytaj oryginał (ang.) |
| electroCore: An Opportunity In Medical And Wellness Device Innovation |
electroCore, Inc. (ECOR) shows promising growth with a 45% YoY revenue increase and a 38% loss reduction, despite missing revenue expectations. The company's gammaCore device is FDA-cleared for headaches, and expanding product lines indicate strong potential and barriers to entry. Management is focused on profitability, rather than international expansion, with high gross margins and decreasing OPEX as a percentage of revenue. |
seekingalpha.com |
2025-01-14 12:17:45 |
Czytaj oryginał (ang.) |
| electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM |
electroCore's gammaCore, an FDA-approved nVNS device, generates recurring revenue and has significant expansion potential within the VA system and other healthcare channels. The company is diversifying with the rugged TAC-STIM for military use and the consumer-focused Truvaga Plus, targeting wellness markets. The recent acquisition of NeuroMetrix's Quell system for fibromyalgia offers revenue and cost synergies, leveraging electroCore's established sales channels. |
seekingalpha.com |
2024-12-30 15:59:33 |
Czytaj oryginał (ang.) |
| electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness |
The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector |
globenewswire.com |
2024-12-17 18:05:00 |
Czytaj oryginał (ang.) |
| Ecora Resources reveals progress at royalty projects |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) provided investors with a general update on its royalty and stream portfolio projects, as well as news that the company will join the FTSE UK SmallCap Index and the FTSE UK All-Share Index, effective 23 December 2024. Of its three producing royalties, the company recalled that Vale Base Metals has completed the Voisey's Bay mine expansion project, transitioning operations from open pit to underground mining. |
proactiveinvestors.co.uk |
2024-12-12 05:09:08 |
Czytaj oryginał (ang.) |
| Ecora Resources to get cobalt royalty boost from Voisey's Bay expansion |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has noted yesterday's confirmation from operator Vale that it had completed the Voisey's Bay Mine Expansion Project. Royalty specialist Ecora has a stream agreement which entitles it to 22.82% of all cobalt production from the Voisey's Bay mine up to 7,600t of finished cobalt, after which the percentage drops to 11.41%. |
proactiveinvestors.co.uk |
2024-12-04 05:11:11 |
Czytaj oryginał (ang.) |
| electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21 |
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place in New York City on November 21, 2024. |
globenewswire.com |
2024-11-14 10:00:00 |
Czytaj oryginał (ang.) |
| electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript |
electroCore, Inc. (NASDAQ:ECOR ) Q3 2024 Earnings Call Transcript November 13, 2024 4:30 PM ET Company Participants Dan Goldberger - CEO & Director Joshua Lev - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the electroCore Third Quarter 2024 Earnings Conference Call. |
seekingalpha.com |
2024-11-13 23:18:46 |
Czytaj oryginał (ang.) |
| ElectroCore, Inc. (ECOR) Reports Q3 Loss, Tops Revenue Estimates |
ElectroCore, Inc. (ECOR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.68 per share a year ago. |
zacks.com |
2024-11-13 20:16:13 |
Czytaj oryginał (ang.) |
| electroCore Announces Third Quarter 2024 Financial Results |
Record quarterly revenues driven by 75% YoY growth of Rx gammaCore™ in the VA/DoD and 147% increase in Truvaga™ sales |
globenewswire.com |
2024-11-13 18:01:00 |
Czytaj oryginał (ang.) |
| ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award |
ROCKAWAY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, is proud to announce that its flagship wellness product, Truvaga Plus, has been awarded the prestigious Men's Health Magazine Tech Award for a pioneering wellness device recognized for innovation and excellence. The award celebrates groundbreaking advancements in health and technology and highlights products that significantly impact men's health and wellness. A link to the article can be found here: Men'sHealth Tech Awards 2025. |
globenewswire.com |
2024-11-12 18:01:00 |
Czytaj oryginał (ang.) |
| Strength Seen in electroCore (ECOR): Can Its 6.0% Jump Turn into More Strength? |
electroCore (ECOR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. |
zacks.com |
2024-11-11 07:16:09 |
Czytaj oryginał (ang.) |
| electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) |
ROCKAWAY, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Thomas Freeburg will join electroCore, effective November 11, 2024, as the Company's VP, Corporate Controller. The Compensation Committee of electroCore's Board of Directors granted 5,000 restricted stock units (“RSUs”) to Mr. Freeburg in connection with the commencement of his employment. The RSUs were granted as an inducement material to Mr. Freeburg's commencement of employment pursuant to NASDAQ Listing Rule 5635(c)(4). 33% of the RSUs will vest on each of the first, second and third anniversaries of the date of grant, subject to Mr. Freeburg's continued employment by the Company on the applicable vesting date. Upon vesting, the RSUs shall be settled in shares of the Company's common stock. |
globenewswire.com |
2024-11-08 18:01:00 |
Czytaj oryginał (ang.) |
| Ecora Resources notes upgrades at Maracás Menchen vanadium project |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has noted an update to the Life of Mine and Pre-Feasibility Study completed on the Maracás Menchen vanadium-titanium operation in Bahia State, Brazil by owner Largo. The highlights of the LOMP and Pre-Feasibility Study include a thirteen-year increase in the reserve-based mine life (out to 2054) and a 67% increase in Mineral Reserves, Ecora added. |
proactiveinvestors.co.uk |
2024-10-28 13:02:02 |
Czytaj oryginał (ang.) |
| Ecora Resources' comments about Voisey Bay encouraging, broker says |
Ecora Resources PLC's (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) comments regarding the Voisey's Bay cobalt operation stream were the most significant component of its third quarter update, according to Peel Hunt. The four deliveries in the quarter matched the total deliveries for all of 2023, notes the broker. |
proactiveinvestors.co.uk |
2024-10-23 08:36:00 |
Czytaj oryginał (ang.) |
| Ecora Resources boosted by cobalt production ramp up |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) portfolio income dropped by 10% in its latest quarter as the contribution from its coking coal royalty at Kestrel fell sharply as expected. Without Kestrel, where mining shifted to areas outside of Ecora's royalty, income in the three months to end September 2024 rose by 4% to US$5 million helped by an almost tripled contribution from the cobalt operation at Voisey Bay. |
proactiveinvestors.co.uk |
2024-10-23 06:44:55 |
Czytaj oryginał (ang.) |
| electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? |
electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
zacks.com |
2024-10-22 15:21:15 |
Czytaj oryginał (ang.) |
| electroCore to Participate at LD Micro Main Event VXII |
Rockaway, New Jersey--(Newsfile Corp. - October 14, 2024) - electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the LD Micro Main Event XVII on Tuesday, October 29 at 4:30 p.m. PT at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. |
newsfilecorp.com |
2024-10-14 12:00:00 |
Czytaj oryginał (ang.) |
| Ecora Resources to switch listing category to ‘commercial companies' on the LSE |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) told investors it intends to move its shares from the ‘Transition' listing category on the London Stock Exchange, to the ‘Commercial Companies' category. These are among the new definitions under the newly reformed listing rules, brought in by the FCA this year. |
proactiveinvestors.co.uk |
2024-10-02 08:21:16 |
Czytaj oryginał (ang.) |
| Ecora Resources just way too cheap, broker suggests |
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) is undervalued by the market after a difficult year says broker Stifel and currently stands at a discount to even the worst-case prognosis. A mining royalty stream specialist, Stifel notes key commodities such as cobalt and metallurgical coal have come under pressure this year. |
proactiveinvestors.co.uk |
2024-09-12 12:52:24 |
Czytaj oryginał (ang.) |
| Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training |
Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot Training Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot Training |
globenewswire.com |
2024-09-10 12:00:00 |
Czytaj oryginał (ang.) |
| Ecora Resources target price raised by Canadian bank |
Ecora Resources PLC's (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) half-year has prompted RBC to remove US$83 million in investments from its 2024/2025 forecasts due to comments on the call on the Incoa project and the unlikely near- term execution of the Piaui option. As a result, net debt and acquisition costs are reduced, increasing RBC's price target from 100p to 120p. |
proactiveinvestors.co.uk |
2024-09-05 13:40:55 |
Czytaj oryginał (ang.) |